Brief: Vaxil‍ Obtains U.S. Patent For Signal Peptide Antibody Platform

Vaxil Bio

01/03/2018 13:45

March 1 (Reuters) - Vaxil Bio Ltd  VXL.V :
    * VAXIL BIO LTD - ‍ OBTAINED A U.S. PATENT FOR ITS SIGNAL
PEPTIDE
ANTIBODY PLATFORM KNOWN AS SPMAB​
    * VAXIL BIO LTD - ‍ SAEID BABAEI HAS RESIGNED FROM HIS ROLE
AS
CHAIRMAN OF BOARD​
    * VAXIL BIO LTD - ‍ISAAC MARESKY HAS ACCEPTED ROLE OF
CHAIRMAN FOR
TIME BEING​

Source text for Eikon:  ID:nMKW6zBrga 
Further company coverage:  VXL.V 

 ((Reuters.Briefs@thomsonreuters.com))